- Home
- KNSA vs OMCL Comparison
KNSA vs OMCL Comparison
Compare KNSA & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- OMCL
- Stock Information
- Founded
- KNSA 2015
- OMCL 1992
- Country
- KNSA United Kingdom
- OMCL United States
- Employees
- KNSA N/A
- OMCL N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- OMCL Computer Manufacturing
- Sector
- KNSA Health Care
- OMCL Technology
- Exchange
- KNSA Nasdaq
- OMCL Nasdaq
- Market Cap
- KNSA 1.7B
- OMCL 2.0B
- IPO Year
- KNSA 2018
- OMCL 2001
- Fundamental
- Price
- KNSA $21.09
- OMCL $44.11
- Analyst Decision
- KNSA Strong Buy
- OMCL Buy
- Analyst Count
- KNSA 5
- OMCL 6
- Target Price
- KNSA $36.60
- OMCL $50.83
- AVG Volume (30 Days)
- KNSA 365.7K
- OMCL 711.7K
- Earning Date
- KNSA 10-29-2024
- OMCL 10-30-2024
- Dividend Yield
- KNSA N/A
- OMCL N/A
- EPS Growth
- KNSA N/A
- OMCL N/A
- EPS
- KNSA N/A
- OMCL N/A
- Revenue
- KNSA $384,098,000.00
- OMCL $1,064,205,999.00
- Revenue This Year
- KNSA $60.05
- OMCL N/A
- Revenue Next Year
- KNSA $36.32
- OMCL $4.97
- P/E Ratio
- KNSA N/A
- OMCL N/A
- Revenue Growth
- KNSA 54.41
- OMCL N/A
- 52 Week Low
- KNSA $15.52
- OMCL $25.12
- 52 Week High
- KNSA $28.15
- OMCL $55.75
- Technical
- Relative Strength Index (RSI)
- KNSA 34.36
- OMCL 46.39
- Support Level
- KNSA $20.41
- OMCL $41.28
- Resistance Level
- KNSA $21.55
- OMCL $53.31
- Average True Range (ATR)
- KNSA 0.87
- OMCL 1.79
- MACD
- KNSA -0.14
- OMCL -0.86
- Stochastic Oscillator
- KNSA 21.90
- OMCL 23.52
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.